Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia

Karolin Trautmann; Christiane Jakob; Ulrich von Grünhagen; Eberhard Schleyer; Tim H. Brümmendorf; Gabriele Siegert; Gerhard Ehninger; Uwe Platzbecker

doi:10.1160/TH12-02-0121

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2012; 108(02): 397-398
DOI: 10.1160/TH12-02-0121

Letters to the Editor

Schattauer GmbH

Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia

Authors

Karolin Trautmann

¹Medical Clinic and Policlinic I, University Hospital Dresden, Germany
Christiane Jakob

²Institute of Pathology, University Hospital Dresden, Germany
Ulrich von Grünhagen

³Oncology Practice, Cottbus, Germany
Eberhard Schleyer

⁴Carl-von-Basedow Clinic, Merseburg, Germany
Tim H. Brümmendorf

⁵Department of Oncology and Hematology, University Hospital Aachen, Germany
Gabriele Siegert

⁶Institute of Clinical Chemistry, University Hospital Dresden, Germany
Gerhard Ehninger

¹Medical Clinic and Policlinic I, University Hospital Dresden, Germany
Uwe Platzbecker

¹Medical Clinic and Policlinic I, University Hospital Dresden, Germany

Abstract

Full Text

References

References
1 Pecci A, Gresele P, Klersy C. et al. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations. Blood 2010; 116: 5832-5870.
2 Gröpper S, Althaus K, Najm J. et al. A patient with Fechtner syndrome successfully treated with romiplostim. Thromb Haemost 2012; 107: 590-591.
3 Pecci A, Barozzi S, d’Amico S. et al. Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation. Thromb Haemost 2012; 107: 1188-1189.
4 Olnes MJ, Scheinberg P, Calvo K. et al. Eltrombopag can stimulate trilineage hematopoiesis with transfusion independence in patients with refractory severe aplastic anemia: results from a phase II trial. Blood (Annual Meeting Abstracts) 2011; 118: 54.
5 Jenkins JM, Williams D, Deng Y. et al. Phase I clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood 2007; 109: 4739-4741.
6 Lipton JM, Ellis SR. Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol Oncol Clin North Am 2009; 23: 261-282.
7 Freedman MH. Inherited Forms of Bone Marrow Failure. Hematology: Basic Principles and Practice. Elsevier; 2005
8 Du HY, Pumbo E, Ivanovich J. et al. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood 2009; 113: 309.
9 Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Hematol 2011; 154: 161-174.
10 Pecci A, Malara A, Badalucco S. et al. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation. Thromb Haemost 2009; 102: 90-96.
11 Nurden P, Nurden AT. Congenital disorders associated with platelet dysfuncions. Thromb Haemost 2008; 99: 253-263.
12 Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009; 35: 189-203.